VAFP
EXAS

Vahanian & Associates Financial Planning’s Exact Sciences EXAS Stock Holding History

Vahanian & Associates Financial Planning’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,926
Closed -$306K – 92
2021
Q4 		$306K Buy
+3,926
New +$346K 0.25% 120

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vahanian & Associates Financial Planning's EXAS Position: Q1 2022 in Review

Vahanian & Associates Financial Planning sold out of Exact Sciences (EXAS) in Q1 2022, closing a stake of 3,926 shares — an estimated $306K sold.

Vahanian & Associates Financial Planning first reported a position in EXAS in Q4 2021 and held it in 1 quarter. The position peaked at $306K in Q4 2021. 559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.

  • Vahanian & Associates Financial Planning reported no remaining Exact Sciences position as of Q1 2022 after selling out during the quarter.
  • Vahanian & Associates Financial Planning sold 3,926 Exact Sciences shares in Q1 2022, an estimated $306K.
  • Vahanian & Associates Financial Planning first reported a position in Exact Sciences in Q4 2021 and held it in 1 quarter.
  • Vahanian & Associates Financial Planning's Exact Sciences position peaked at $306K in Q4 2021.
  • 559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.

Based on Vahanian & Associates Financial Planning's 13F filing for Q1 2022, filed 27 Apr 2022.